Document 0666
 DOCN  M95A0666
 TI    3TC and AZT. 
 DT    9510
 SO    Treat Rev. 1995 Mar/Apr;(no 17):2. Unique Identifier : AIDSLINE
       AIDS/95700317
 AB    The combination of AZT and 3TC has proven to be effective in reducing
       HIV levels in some people in several clinical trials recently reported
       on at a scientific conference in Scotland. People taking this
       combination did not experience any more side effects than if they were
       taking AZT alone. It was also discovered in test tube studies and in
       Phase I and Phase II studies that 3TC was very effective against the
       hepatitis B virus. It has not yet been determined whether this
       combination helps HIV positive people live longer. Glaxo Pharmaceuticals
       has made 3TC available through a special program while the drug is
       awaiting approval from the Food and Drug Administration (FDA). For more
       information on how to get 3TC and other experimental or approved drugs,
       call (800) 734-7104.
 DE    Antiviral Agents/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS/  *THERAPEUTIC
       USE  Drug Therapy, Combination  HIV Infections/*DRUG THERAPY  Human
       Zalcitabine/ANALOGS & DERIVATIVES/ADMINISTRATION & DOSAGE/ADVERSE
       EFFECTS/*THERAPEUTIC USE  Zidovudine/ADMINISTRATION & DOSAGE/ADVERSE
       EFFECTS/*THERAPEUTIC  USE  NEWSLETTER ARTICLE  CLINICAL TRIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).